Vyas Tungaturti is an M&A advisor with nearly two decades on the execution side of deals: first at Deloitte Consulting, then, since 2018, as an independent advisor to Big 4 firms on due diligence, integration and carve-outs across more than 50 transactions. He founded CorpDev.Org, runs CogTech, and builds Kai, AI-native due diligence for M&A and PE teams: upload a data room and within hours Kai has read every document, found every risk and opportunity, priced with evidence, and traced every figure to its source.
In a landmark move with national implications, Oregon lawmakers passed Senate Bill 951 on May 28, 2025, enacting the most comprehensive state-level restrictions on corporate control of medical...
Yale University's endowment is finalizing a landmark $2.5 billion secondary sale of private equity stakes, marking the largest portfolio rebalancing in its 307-year history . This transaction –...
In a move signaling renewed confidence in space infrastructure investments, reusable rocket developer iRocket announced a $400 million SPAC merger with BPGC Acquisition Corp., chaired by former U.S....
In a bold strategic maneuver, HSBC has committed $4 billion to turbocharge its private credit operations through HSBC Asset Management, signaling one of 2025's most consequential shifts in global...
Swiss private markets giant Partners Group has positioned itself at the forefront of America's energy infrastructure transformation with its $450 million acquisition of PowerTransitions, a...
German pharmaceutical giant Stada Arzneimittel AG stands at an inflection point as private equity owners Bain Capital and Cinven explore dual-track exit strategies. Recent reports indicate advanced...
In a landmark transaction reshaping the industrial technology landscape, Chart Industries (NYSE: GTLS) and Flowserve Corporation (NYSE: FLS) announced an all-stock merger of equals creating a $19...
The $1.3 billion strategic investment from Carlyle's Global Credit platform into Trucordia represents a watershed moment for the insurance brokerage sector, valuing the Utah-based firm at $5.7...
The $1 billion acquisition of Barrick Gold’s 50% stake in Alaska’s Donlin Gold project by NOVAGOLD Resources and Paulson Advisers represents a strategic realignment in North American gold...
Sanofi's landmark $9.1 billion acquisition of Blueprint Medicines marks a pivotal shift in the global biopharma landscape, combining immediate revenue generation with long-term immunology pipeline...
